Code No. 1151/PCI
FACULTY OF PHARMACY
--- Content provided by FirstRanker.com ---
M. Pharmacy (Pharma. Analysis) I-Semester (PCI) (Main) Examination, February 2018
Subject: Advanced Pharmaceutical Analysis
Time: 3 Hrs Max. Marks: 75
Note: Answer any five questions. All questions carry equal marks.
- (a) Explain in-detail about impurity profiling of new drug product. (10)
--- Content provided by FirstRanker.com ---
(b) Write classification and identification of elemental impurities. (5) - (a) Explain briefly protocol adopted for stability testing of drugs. (8)
(b) Describe briefly accelerated stability studies and determination of shelf-life. (7) - (a) Explain various principles and testing procedures involved in degradant characterization. (8)
(b) Describe ICH stability guidelines for biological products. (7) - (a) Write an account on requirements for stability testing of phytopharmaceuticals. (7)
(b) Describe the principle and methods involved in HPLC finger printing with suitable examples. (8) - (a) Mention different types of tetanus vaccine. Explain bioassay of adsorbed tetanus vaccine. (8)
(b) Describe the principle and procedure involved in bioassay of any one biological product. (7) - (a) Describe the principle, instrumentation and applications of radio immune assay. (8)
--- Content provided by FirstRanker.com ---
(b) Describe procedures for separation of bound and unbound drug during immunoassay. (7) - (a) Write an account on elemental impurities and their determination. (10)
(b) Explain basic principle and applications of PCR studies. (5) - (a) Write classification, potential sources, control and identification of residual solvent impurities. (10)
(b) Describe the production of antibodies. (5)
--- Content provided by FirstRanker.com ---
--- Content provided by FirstRanker.com ---
This download link is referred from the post: OU M.Pharm Question Papers Last 10 Years 2010-2020 || Osmania University
--- Content provided by FirstRanker.com ---